170 related articles for article (PubMed ID: 37356958)
1. [Research Progress of m6A Demethylase FTO and Its Inhibitors in Acute Myeloid Leukemia --Review].
Fang ZH; Zheng SY; Feng WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):902-906. PubMed ID: 37356958
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
You Y; Fu Y; Huang M; Shen D; Zhao B; Liu H; Zheng Y; Huang L
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628623
[TBL] [Abstract][Full Text] [Related]
3. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
[TBL] [Abstract][Full Text] [Related]
4. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
Azzam SK; Alsafar H; Sajini AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
[TBL] [Abstract][Full Text] [Related]
5. FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N
Li Z; Weng H; Su R; Weng X; Zuo Z; Li C; Huang H; Nachtergaele S; Dong L; Hu C; Qin X; Tang L; Wang Y; Hong GM; Huang H; Wang X; Chen P; Gurbuxani S; Arnovitz S; Li Y; Li S; Strong J; Neilly MB; Larson RA; Jiang X; Zhang P; Jin J; He C; Chen J
Cancer Cell; 2017 Jan; 31(1):127-141. PubMed ID: 28017614
[TBL] [Abstract][Full Text] [Related]
6. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.
Huang Y; Su R; Sheng Y; Dong L; Dong Z; Xu H; Ni T; Zhang ZS; Zhang T; Li C; Han L; Zhu Z; Lian F; Wei J; Deng Q; Wang Y; Wunderlich M; Gao Z; Pan G; Zhong D; Zhou H; Zhang N; Gan J; Jiang H; Mulloy JC; Qian Z; Chen J; Yang CG
Cancer Cell; 2019 Apr; 35(4):677-691.e10. PubMed ID: 30991027
[TBL] [Abstract][Full Text] [Related]
7. Structure-Activity Relationships and Antileukemia Effects of the Tricyclic Benzoic Acid FTO Inhibitors.
Liu Z; Duan Z; Zhang D; Xiao P; Zhang T; Xu H; Wang CH; Rao GW; Gan J; Huang Y; Yang CG; Dong Z
J Med Chem; 2022 Aug; 65(15):10638-10654. PubMed ID: 35793358
[TBL] [Abstract][Full Text] [Related]
8. Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m
Sun K; Du Y; Hou Y; Zhao M; Li J; Du Y; Zhang L; Chen C; Yang H; Yan F; Su R
Theranostics; 2021; 11(12):5831-5846. PubMed ID: 33897884
[No Abstract] [Full Text] [Related]
9. The Yin and Yang of RNA Methylation: An Imbalance of Erasers Enhances Sensitivity to FTO Demethylase Small-Molecule Targeting in Leukemia Stem Cells.
Van Der Werf I; Jamieson C
Cancer Cell; 2019 Apr; 35(4):540-541. PubMed ID: 30991023
[TBL] [Abstract][Full Text] [Related]
10. Novel positioning from obesity to cancer: FTO, an m
Chen J; Du B
J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
[TBL] [Abstract][Full Text] [Related]
11. Chemical Inhibitors Targeting the Oncogenic m
Huang Y; Xia W; Dong Z; Yang CG
Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
[TBL] [Abstract][Full Text] [Related]
12. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
[TBL] [Abstract][Full Text] [Related]
13. Increased m6A-RNA methylation and demethylase FTO suppression is associated with silica-induced pulmonary inflammation and fibrosis.
Xu Y; Wang L; Qian R; Zhao M; Chen X; Sun D; Wang Y; Cheng W; Chen Y; He Q; Dai Y; Yao Y
Toxicology; 2023 Dec; 500():153673. PubMed ID: 37979906
[TBL] [Abstract][Full Text] [Related]
14. Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties.
Xiao P; Duan Z; Liu Z; Chen L; Zhang D; Liu L; Zhou C; Gan J; Dong Z; Yang CG
J Med Chem; 2023 Jul; 66(14):9731-9752. PubMed ID: 37418628
[TBL] [Abstract][Full Text] [Related]
15. Structural characteristics of small-molecule inhibitors targeting
Gao S; Li X; Zhang M; Zhang N; Wang R; Chang J
Future Med Chem; 2021 Sep; 13(17):1475-1489. PubMed ID: 34240624
[TBL] [Abstract][Full Text] [Related]
16. Emerging Role and Mechanism of the
Xu ZY; Jing X; Xiong XD
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238719
[TBL] [Abstract][Full Text] [Related]
17. The role of the m6A/m demethylase FTO in memory is both task and sex-dependent in mice.
Leonetti AM; Galluzzo IR; McLean TAD; Stefanelli G; Ramnaraign F; Holm S; Winston SM; Reeves IL; Brimble MA; Walters BJ
Neurobiol Learn Mem; 2024 Apr; 210():107903. PubMed ID: 38403011
[TBL] [Abstract][Full Text] [Related]
18. The role of m6A demethylases in lung cancer: diagnostic and therapeutic implications.
Yu M; Ji W; Yang X; Tian K; Ma X; Yu S; Chen L; Zhao X
Front Immunol; 2023; 14():1279735. PubMed ID: 38094306
[TBL] [Abstract][Full Text] [Related]
19. FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.
Sun Z; Sun X; Qin G; Li Y; Zhou G; Jiang X
Epigenetics; 2023 Dec; 18(1):2242688. PubMed ID: 37538000
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]